AGÕæÈ˹ٷ½

STOCK TITAN

Cardlytics Announces Second Quarter 2025 Financial Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

ATLANTA--(BUSINESS WIRE)-- Cardlytics, Inc. (NASDAQ: CDLX), a commerce media platform, today announced financial results for the second quarter ended June 30, 2025.

"Building on the progress we've made over the past year, we are navigating headwinds by doubling down on our diversification efforts and reinforcing our unique network capabilities," said Amit Gupta, CEO of Cardlytics. "We believe our strategic shifts will position us for long-term profitable growth and enable us to deliver on the promise to our stakeholders."

Second Quarter 2025 Financial Results

  • Revenue was $63.2 million, a decrease of 9% year-over-year compared to $69.6 million in the second quarter of 2024.
  • Billings, a non-GAAP metric, was $104.0 million, a decrease of 6% year-over-year compared to $110.4 million in the second quarter of 2024.
  • Adjusted Contribution, a non-GAAP metric, was $36.1 million, a decrease of 1% year-over-year compared to $36.4 million in the second quarter of 2024.
  • Net Loss was $(9.3) million, or $(0.18) per diluted share, based on 52.8 million fully diluted weighted-average common shares, compared to a Net Loss of $(4.3) million, or $(0.09) per diluted share, based on 49.1 million fully diluted weighted-average common shares in the second quarter of 2024.
  • Adjusted EBITDA, a non-GAAP metric, was $2.7 million compared to $(2.3) million in the second quarter of 2024.
  • Adjusted Net Loss was $(7.0) million, or $(0.13) per diluted share, based on 52.8 million fully diluted weighted-average common shares, compared to Adjusted Net Loss of $(7.6) million, or $(0.15) per diluted share, based on 49.1 million fully diluted weighted-average common shares in the second quarter of 2024.
  • Net cash used in operating activities was $1.2 million, compared to $4.4 million in the second quarter of 2024.
  • Free Cash Flow, a non-GAAP metric, was $(3.4) million, compared to $(0.4) million in the second quarter of 2024.

Key Metrics

  • Cardlytics monthly qualified users ("MQUs") were 224.5 million, an increase of 19% year-over-year, compared to 188.8 million in the second quarter of 2024.
  • Cardlytics adjusted contribution per user ("ACPU") was $0.14 compared to $0.16 in the second quarter of 2024.

Definitions of MQUs and ACPU are included below under the caption “Other Performance Metrics."

CARDLYTICS, INC.

SUMMARY OF GAAP AND NON-GAAP RESULTS (UNAUDITED)

(Dollars in thousands)

Ìý Ìý

Ìý

Three Months Ended

June 30,

Ìý

Ìý

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Ìý

Change %

Billings(1)

$

104,048

Ìý

Ìý

$

110,389

Ìý

Ìý

(6

)%

Consumer Incentives

Ìý

40,799

Ìý

Ìý

Ìý

40,753

Ìý

Ìý

�

%

Revenue

Ìý

63,249

Ìý

Ìý

Ìý

69,636

Ìý

Ìý

(9

)%

Partner Share and other third-party costs

Ìý

27,103

Ìý

Ìý

Ìý

33,258

Ìý

Ìý

(19

)%

Adjusted Contribution(1)

Ìý

36,146

Ìý

Ìý

Ìý

36,378

Ìý

Ìý

(1

)%

Delivery costs

Ìý

6,883

Ìý

Ìý

Ìý

7,661

Ìý

Ìý

(10

)%

Gross Profit

$

29,263

Ìý

Ìý

$

28,717

Ìý

Ìý

2

%

Net Loss

$

(9,283

)

Ìý

$

(4,257

)

Ìý

118

%

Adjusted EBITDA(1)

$

2,703

Ìý

Ìý

$

(2,285

)

Ìý

na

ÌýÌý

Ìý

Ìý

Ìý

Ìý

Ìý

Adjusted Contribution

Ìý

Ìý

Ìý

Ìý

Ìý

% of Billings

Ìý

34.7

%

Ìý

Ìý

33.0

%

Ìý

Ìý

% of Revenue

Ìý

57.1

%

Ìý

Ìý

52.2

%

Ìý

Ìý

Adjusted EBITDA

Ìý

Ìý

Ìý

Ìý

Ìý

% of Billings

Ìý

2.6

%

Ìý

Ìý

(2.1

)%

Ìý

Ìý

% of Revenue

Ìý

4.3

%

Ìý

Ìý

(3.3

)%

Ìý

Ìý

(1)

Billings, Adjusted Contribution and Adjusted EBITDA are non-GAAP measures. Reconciliations of these non-GAAP measures to the most comparable GAAP measures are presented below under the headings "Reconciliation of GAAP Revenue to Billings," "Reconciliation of GAAP Gross Profit to Adjusted Contribution" and "Reconciliation of GAAP Net Loss to Adjusted EBITDA."

Third Quarter 2025 Financial Expectations

Cardlytics anticipates Billings, Revenue, Adjusted Contribution and Adjusted EBITDA to be in the following ranges (in millions, except for percentage change rates):

Ìý

Q3 2025
Guidance

Ìý

YoY Change

Billings(1)

$87.0 - $95.0

Ìý

(22%) - (15%)

Revenue

$52.2 - $58.2

Ìý

(22%) - (13%)

Adjusted Contribution(2)

$30.3 - $34.3

Ìý

(17%) - (6%)

Adjusted EBITDA(2)

($2.3) - $2.7

Ìý

($0.5) - $4.5

(1)

A reconciliation of Billings to GAAP Revenue on a forward-looking basis is presented below under the heading "Reconciliation of Forecasted GAAP Revenue to Billings."

(2)

A reconciliation of Adjusted Contribution to GAAP Gross Profit and a reconciliation of Adjusted EBITDA to Net Loss on a forward-looking basis is not available without unreasonable efforts due to the high variability, complexity and low visibility with respect to the items excluded from this non-GAAP measure.

Earnings Teleconference Information

Cardlytics will discuss its second quarter 2025 financial results during a live audio webcast today, August 6, 2025, at 5:00 PM ET / 2:00 PM PT. Following the completion of the call, a recorded replay of the webcast will be available on Cardlytics� website.

About Cardlytics

Cardlytics (NASDAQ: CDLX) is a commerce media platform, powered by our publishers� first-party purchase data, that makes commerce smarter and more rewarding for everyone. We offer a range of solutions to help advertisers and publishers grow and strengthen customer loyalty. With visibility into approximately half of all card-based transactions in the U.S. and a quarter in the U.K., Cardlytics enables advertisers to engage consumers at scale and drive incremental sales through our industry-leading card-linked offer network. Publisher partners can enhance their platforms with relevant and personalized offers that improve the shopping experience for their customers. Cardlytics also offers identity resolution capabilities through Bridg, which helps convert anonymous shoppers into known and reachable customers. Headquartered in Atlanta, Cardlytics has offices in Menlo Park, Los Angeles, Champaign, New York and London. Learn more at or follow us on LinkedIn.

Cautionary Language Concerning Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements related to our strategic initiatives to strengthen our business and market position and to our financial guidance for the third quarter of 2025. These forward-looking statements are made as of the date they were first issued and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as "expect," "anticipate," "should," "believe," "hope," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "might," "could," "intend," or variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond our control.

Our actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: risks related to unfavorable conditions, including, but not limited to, inflationary pressure or the imposition of tariffs and other trade protection measures, in the global economy and the industries that we serve; our quarterly operating results have fluctuated and may continue to vary from period to period; our ability to sustain our revenue growth and billings; risks related to our substantial dependence on our Cardlytics platform; risks related to our substantial dependence on JPMorgan Chase Bank, National Association (“Chase�), Bank of America, National Association (“Bank of America�), Wells Fargo Bank, National Association (“Wells Fargo�), American Express Travel Related Services Company, Inc. (“American Express�) and a limited number of other financial institution (“FI�) partners; risks related to our ability to maintain relationships with Chase, Wells Fargo and Bank of America; the amount and timing of budgets by marketers, which are affected by budget cycles, economic conditions and other factors; our ability to generate sufficient revenue to offset contractual commitments to FI partners; our ability to attract new partners, including FI partners, and maintain relationships with bank processors and digital banking providers; risks related to our competitive market, including our ability to compete successfully with our current or future competitors; our ability to maintain relationships with marketers; our ability to adapt to changing market conditions, including our ability to adapt to changes in consumer habits, negotiate fee arrangements with new and existing partners and retailers, and develop and launch new services and features; and other risks detailed in the “Risk Factors� section of our Form 10-Q filed with the Securities and Exchange Commission on August 6, 2025 and in subsequent periodic reports that we file with the Securities and Exchange Commission. Past performance is not necessarily indicative of future results.

The forward-looking statements included in this press release represent our views as of the date of this press release. We anticipate that subsequent events and developments will cause our views to change. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

Non-GAAP Measures and Other Performance Metrics

To supplement the financial measures presented in our press release and related conference call or webcast in accordance with generally accepted accounting principles in the United States (“GAAP�), we also present the following non-GAAP measures of financial performance in this press release: Billings, Adjusted Contribution, Adjusted EBITDA, Adjusted Net Loss, Adjusted Net Loss per share and Free Cash Flow, as well as certain other performance metrics, such as MQUs and ACPU.

A “non-GAAP financial measure� refers to a numerical measure of our historical or future financial performance or financial position that is included in (or excluded from) the most directly comparable measure calculated and presented in accordance with GAAP in our financial statements. We provide certain non-GAAP measures as additional information relating to our operating results as a complement to results provided in accordance with GAAP. The non-GAAP financial information presented herein should be considered in conjunction with, and not as a substitute for or superior to, the financial information presented in accordance with GAAP and should not be considered a measure of liquidity. There are significant limitations associated with the use of non-GAAP financial measures. Further, these measures may differ from the non-GAAP information, even where similarly titled, used by other companies and therefore should not be used to compare our performance to that of other companies.

We have presented Billings, Adjusted Contribution, Adjusted EBITDA, Adjusted Net Loss and Adjusted Net Loss per share as non-GAAP financial measures in this press release. Billings represents the gross amount billed to customers and marketers for services in order to generate revenue. Cardlytics platform Billings is recognized gross of both Consumer Incentives and Partner Share. Cardlytics platform GAAP Revenue is recognized net of Consumer Incentives and gross of Partner Share. Bridg platform Billings is the same as Bridg platform GAAP Revenue. Adjusted Contribution measures the degree by which Revenue generated from our marketers exceeds the cost to obtain the purchase data and the digital advertising space from our partners. Adjusted Contribution demonstrates how incremental Revenue on our platforms generates incremental amounts to support our sales and marketing, research and development, general and administrative and other investments. Adjusted Contribution is calculated by taking our total Revenue less our Partner Share and other third-party costs. Adjusted Contribution does not take into account all costs associated with generating Revenue from advertising campaigns, including sales and marketing expenses, research and development expenses, general and administrative expenses and other expenses, which we do not take into consideration when making decisions on how to manage our advertising campaigns. Management views Adjusted Contribution as the most relevant metric to measure the financial performance as it reflects the dollars we keep after all of our partners are paid. Adjusted EBITDA represents our Net Loss before interest expense, net; depreciation and amortization; stock-based compensation expense; foreign currency (gain) loss; gain on debt extinguishment; acquisition, integration and divestiture costs; loss (gain) on disposal or divestiture; change in contingent consideration; reduction in force; and, in applicable periods, certain other income and expense items, such as impairment of goodwill and intangible assets; income tax benefit; and deferred implementation costs. Adjusted Net Loss as our Net Loss before stock-based compensation expense; foreign currency (gain) loss; gain on debt extinguishment; acquisition, integration and divestiture costs; amortization of acquired intangibles; loss (gain) on disposal or divestiture; change in contingent consideration; reduction in force; and, in applicable periods, certain other income and expense items, such as impairment of goodwill and intangible assets and income tax benefit. We define Adjusted Net Loss per share as Adjusted Net Loss divided by our weighted-average common shares outstanding, diluted. We define Free Cash Flow as net cash provided by (used in) operating activities, plus acquisition of property and equipment and capitalized software development costs and, in applicable periods, acquisition of patents. We believe free cash flow is useful to measure the funds generated in a given period that are available for distribution or to sustain the business. We believe this supplemental information enhances stockholders' ability to evaluate our performance.

We believe the use of non-GAAP financial measures, as a supplement to GAAP measures, is useful to investors in that they eliminate items that are either not part of our core operations or do not require a cash outlay, such as stock-based compensation expense. Management uses these non-GAAP financial measures when evaluating operating performance and for internal planning and forecasting purposes. We believe that these non-GAAP financial measures help indicate underlying trends in the business, are important in comparing current results with prior period results and are useful to investors and financial analysts in assessing operating performance.

We define MQUs as targetable customers that have made a transaction using their account with an FI Partner or non-FI Partner in a given month, excluding pilot supply during the ramp up period, and whose transaction data was shared with Cardlytics. We then calculate a monthly average of these MQUs for the periods presented. We believe that the number of MQUs is an indicator of the Cardlytics platform's ability to drive engagement and is reflective of the consumer base and insights that we offer to marketers. We define ACPU as the Cardlytics platform Adjusted Contribution generated in the applicable period, divided by Cardlytics average MQUs in the applicable period. We believe that Adjusted Contribution is the most relevant metric as it reflects the value Cardlytics keeps after subtracting out rewards, Partner Share and other third-party costs. We believe that ACPU measures the Cardlytics platform's efficiency in converting marketer budgets into the value generated by customer engagement.

CARDLYTICS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(Amounts in thousands, except par value amounts)

Ìý Ìý

Ìý

June 30, 2025

Ìý

December 31, 2024

Assets

Ìý

Ìý

Ìý

Current assets:

Ìý

Ìý

Ìý

Cash and cash equivalents

$

46,745

Ìý

Ìý

$

65,594

Ìý

Accounts receivable and contract assets, net

Ìý

93,189

Ìý

Ìý

Ìý

103,252

Ìý

Other receivables

Ìý

3,431

Ìý

Ìý

Ìý

3,801

Ìý

Prepaid expenses and other assets

Ìý

7,035

Ìý

Ìý

Ìý

5,336

Ìý

Total current assets

Ìý

150,400

Ìý

Ìý

Ìý

177,983

Ìý

Long-term assets:

Ìý

Ìý

Ìý

Property and equipment, net

Ìý

2,389

Ìý

Ìý

Ìý

2,596

Ìý

Right-of-use assets under operating leases, net

Ìý

4,633

Ìý

Ìý

Ìý

6,341

Ìý

Intangible assets, net

Ìý

8,462

Ìý

Ìý

Ìý

11,371

Ìý

Goodwill

Ìý

159,429

Ìý

Ìý

Ìý

159,429

Ìý

Capitalized software development costs, net

Ìý

34,415

Ìý

Ìý

Ìý

33,341

Ìý

Other long-term assets, net

Ìý

1,406

Ìý

Ìý

Ìý

1,650

Ìý

Total assets

$

361,134

Ìý

Ìý

$

392,711

Ìý

Liabilities and stockholders' equity

Ìý

Ìý

Ìý

Current liabilities:

Ìý

Ìý

Ìý

Accounts payable

$

1,945

Ìý

Ìý

$

3,689

Ìý

Accrued liabilities:

Ìý

Ìý

Ìý

Accrued compensation

Ìý

7,244

Ìý

Ìý

Ìý

5,494

Ìý

Accrued expenses

Ìý

6,457

Ìý

Ìý

Ìý

7,175

Ìý

Partner Share liability

Ìý

27,196

Ìý

Ìý

Ìý

32,479

Ìý

Consumer Incentive liability

Ìý

35,996

Ìý

Ìý

Ìý

45,513

Ìý

Short-term debt

Ìý

46,009

Ìý

Ìý

Ìý

45,863

Ìý

Deferred revenue

Ìý

3,103

Ìý

Ìý

Ìý

2,154

Ìý

Current operating lease liabilities

Ìý

1,199

Ìý

Ìý

Ìý

2,025

Ìý

Current contingent consideration

Ìý

�

Ìý

Ìý

Ìý

4,563

Ìý

Total current liabilities

Ìý

129,149

Ìý

Ìý

Ìý

148,955

Ìý

Long-term liabilities:

Ìý

Ìý

Ìý

Convertible senior notes, net

Ìý

168,289

Ìý

Ìý

Ìý

167,729

Ìý

Long-term operating lease liabilities

Ìý

4,915

Ìý

Ìý

Ìý

6,034

Ìý

Long-term deferred revenue

Ìý

75

Ìý

Ìý

Ìý

�

Ìý

Total liabilities

$

302,428

Ìý

Ìý

$

322,718

Ìý

Stockholders� equity:

Ìý

Ìý

Ìý

Common stock, $0.0001 par value�100,000 shares authorized, 52,994 and 51,257 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively

$

10

Ìý

Ìý

$

10

Ìý

Additional paid-in capital

Ìý

1,385,465

Ìý

Ìý

Ìý

1,366,958

Ìý

Accumulated other comprehensive (loss) income

Ìý

(3,628

)

Ìý

Ìý

3,601

Ìý

Accumulated deficit

Ìý

(1,323,141

)

Ìý

Ìý

(1,300,576

)

Total stockholders� equity

Ìý

58,706

Ìý

Ìý

Ìý

69,993

Ìý

Total liabilities and stockholders� equity

$

361,134

Ìý

Ìý

$

392,711

Ìý

CARDLYTICS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(Amounts in thousands, except per share amounts)

Ìý Ìý

Ìý

Three Months Ended
June 30,

Ìý

Six Months Ended
June 30,

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Revenue

$

63,249

Ìý

Ìý

$

69,636

Ìý

Ìý

$

125,147

Ìý

Ìý

$

137,244

Ìý

Costs and expenses:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Partner Share and other third-party costs

Ìý

27,103

Ìý

Ìý

Ìý

33,258

Ìý

Ìý

Ìý

56,553

Ìý

Ìý

Ìý

63,801

Ìý

Delivery costs

Ìý

6,883

Ìý

Ìý

Ìý

7,661

Ìý

Ìý

Ìý

14,171

Ìý

Ìý

Ìý

13,834

Ìý

Sales and marketing expense

Ìý

11,335

Ìý

Ìý

Ìý

14,025

Ìý

Ìý

Ìý

24,089

Ìý

Ìý

Ìý

28,143

Ìý

Research and development expense

Ìý

11,295

Ìý

Ìý

Ìý

13,470

Ìý

Ìý

Ìý

23,001

Ìý

Ìý

Ìý

26,518

Ìý

General and administrative expense

Ìý

12,905

Ìý

Ìý

Ìý

16,151

Ìý

Ìý

Ìý

26,683

Ìý

Ìý

Ìý

30,636

Ìý

Acquisition, integration and divestiture costs

Ìý

�

Ìý

Ìý

Ìý

162

Ìý

Ìý

Ìý

�

Ìý

Ìý

Ìý

162

Ìý

Change in contingent consideration

Ìý

42

Ìý

Ìý

Ìý

(5,808

)

Ìý

Ìý

102

Ìý

Ìý

Ìý

9

Ìý

Loss (gain) on disposal or divestiture

Ìý

200

Ìý

Ìý

Ìý

�

Ìý

Ìý

Ìý

(5,150

)

Ìý

Ìý

�

Ìý

Depreciation and amortization expense

Ìý

6,275

Ìý

Ìý

Ìý

6,529

Ìý

Ìý

Ìý

12,566

Ìý

Ìý

Ìý

12,779

Ìý

Total costs and expenses

Ìý

76,038

Ìý

Ìý

Ìý

85,448

Ìý

Ìý

Ìý

152,015

Ìý

Ìý

Ìý

175,882

Ìý

Operating Loss

Ìý

(12,789

)

Ìý

Ìý

(15,812

)

Ìý

Ìý

(26,868

)

Ìý

Ìý

(38,638

)

Other income (expense):

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Interest expense, net

Ìý

(1,943

)

Ìý

Ìý

(1,561

)

Ìý

Ìý

(3,773

)

Ìý

Ìý

(2,380

)

Foreign currency gain (loss)

Ìý

5,449

Ìý

Ìý

Ìý

99

Ìý

Ìý

Ìý

8,076

Ìý

Ìý

Ìý

(531

)

Gain on debt extinguishment

Ìý

�

Ìý

Ìý

Ìý

13,017

Ìý

Ìý

Ìý

�

Ìý

Ìý

Ìý

13,017

Ìý

Total other income

Ìý

3,506

Ìý

Ìý

Ìý

11,555

Ìý

Ìý

Ìý

4,303

Ìý

Ìý

Ìý

10,106

Ìý

Loss before income taxes

Ìý

(9,283

)

Ìý

Ìý

(4,257

)

Ìý

Ìý

(22,565

)

Ìý

Ìý

(28,532

)

Net Loss

$

(9,283

)

Ìý

$

(4,257

)

Ìý

$

(22,565

)

Ìý

$

(28,532

)

Net Loss per share, basic and diluted

$

(0.18

)

Ìý

$

(0.09

)

Ìý

$

(0.43

)

Ìý

$

(0.62

)

Weighted-average common shares outstanding, basic and diluted

Ìý

52,750

Ìý

Ìý

Ìý

49,056

Ìý

Ìý

Ìý

52,309

Ìý

Ìý

Ìý

46,168

Ìý

CARDLYTICS, INC.

STOCK-BASED COMPENSATION EXPENSE (UNAUDITED)

(Amounts in thousands)

Ìý Ìý

Ìý

Three Months Ended

June 30,

Ìý

Six Months Ended

June 30,

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Delivery costs

$

464

Ìý

Ìý

$

721

Ìý

Ìý

$

1,001

Ìý

Ìý

$

1,364

Ìý

Sales and marketing expense

Ìý

1,072

Ìý

Ìý

Ìý

2,903

Ìý

Ìý

Ìý

3,150

Ìý

Ìý

Ìý

6,044

Ìý

Research and development expense

Ìý

3,165

Ìý

Ìý

Ìý

4,633

Ìý

Ìý

Ìý

5,939

Ìý

Ìý

Ìý

8,583

Ìý

General and administrative expense

Ìý

2,800

Ìý

Ìý

Ìý

4,387

Ìý

Ìý

Ìý

6,105

Ìý

Ìý

Ìý

7,638

Ìý

Total stock-based compensation expense

$

7,501

Ìý

$

12,644

Ìý

$

16,195

Ìý

$

23,629

CARDLYTICS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(Amounts in thousands)

Ìý Ìý

Ìý

Six Months Ended

June 30,

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Operating activities

Ìý

Ìý

Ìý

Net Loss

$

(22,565

)

Ìý

$

(28,532

)

Adjustments to reconcile net loss to net cash used in operating activities:

Ìý

Ìý

Ìý

Credit loss expense

Ìý

1,833

Ìý

Ìý

Ìý

3,761

Ìý

Depreciation and amortization

Ìý

12,566

Ìý

Ìý

Ìý

12,779

Ìý

Amortization of financing costs charged to interest expense

Ìý

804

Ìý

Ìý

Ìý

850

Ìý

Amortization of right-of-use assets

Ìý

1,274

Ìý

Ìý

Ìý

1,072

Ìý

Gain on disposal or divestiture

Ìý

(5,150

)

Ìý

Ìý

�

Ìý

Gain on debt extinguishment

Ìý

�

Ìý

Ìý

Ìý

(13,017

)

Stock-based compensation expense

Ìý

16,195

Ìý

Ìý

Ìý

23,629

Ìý

Change in contingent consideration

Ìý

102

Ìý

Ìý

Ìý

9

Ìý

Other non-cash (income) expense, net

Ìý

(8,076

)

Ìý

Ìý

663

Ìý

Change in operating assets and liabilities:

Ìý

Ìý

Ìý

Accounts receivable

Ìý

10,165

Ìý

Ìý

Ìý

14,783

Ìý

Prepaid expenses and other assets

Ìý

(1,625

)

Ìý

Ìý

(393

)

Accounts payable

Ìý

(1,837

)

Ìý

Ìý

810

Ìý

Other accrued expenses

Ìý

920

Ìý

Ìý

Ìý

(7,253

)

Partner Share liability

Ìý

(5,913

)

Ìý

Ìý

(15,114

)

Consumer Incentive liability

Ìý

(4,174

)

Ìý

Ìý

(7,234

)

Net cash used in operating activities

Ìý

(5,481

)

Ìý

Ìý

(13,188

)

Investing activities

Ìý

Ìý

Ìý

Acquisition of property and equipment

Ìý

(441

)

Ìý

Ìý

(932

)

Capitalized software development costs

Ìý

(8,320

)

Ìý

Ìý

(8,673

)

Business divestiture and acquisitions, net of cash acquired

Ìý

200

Ìý

Ìý

Ìý

202

Ìý

Net cash used in investing activities

Ìý

(8,561

)

Ìý

Ìý

(9,403

)

Financing activities

Ìý

Ìý

Ìý

Settlement of contingent consideration

Ìý

(5,000

)

Ìý

Ìý

(14,166

)

Principal payments of the 2018 Line of Credit

Ìý

�

Ìý

Ìý

Ìý

(30,000

)

Principal payments of 2020 Convertible Senior Notes

Ìý

�

Ìý

Ìý

Ìý

(169,291

)

Proceeds from issuance of 2024 Convertible Senior Notes

Ìý

�

Ìý

Ìý

Ìý

172,500

Ìý

Proceeds from termination of capped calls related to convertible notes

Ìý

�

Ìý

Ìý

Ìý

115

Ìý

Proceeds from issuance of common stock

Ìý

�

Ìý

Ìý

Ìý

48,634

Ìý

Equity issuance costs

Ìý

�

Ìý

Ìý

Ìý

(190

)

Debt issuance costs

Ìý

(93

)

Ìý

Ìý

(5,568

)

Net cash (used in) provided by financing activities

Ìý

(5,093

)

Ìý

Ìý

2,034

Ìý

Effect of exchange rates on cash and cash equivalents

Ìý

286

Ìý

Ìý

Ìý

(25

)

Net decrease in cash and cash equivalents

Ìý

(18,849

)

Ìý

Ìý

(20,582

)

Cash and cash equivalents � Beginning of period

Ìý

65,594

Ìý

Ìý

Ìý

91,830

Ìý

Cash and cash equivalents � End of period

$

46,745

Ìý

Ìý

$

71,248

Ìý

CARDLYTICS, INC.

RECONCILIATION OF GAAP REVENUE TO BILLINGS (UNAUDITED)

(Amounts in thousands)

Ìý Ìý

Ìý

Three Months Ended

June 30,

Ìý

Six Months Ended

June 30,

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Consolidated

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Revenue

$

63,249

Ìý

Ìý

$

69,636

Ìý

Ìý

$

125,147

Ìý

Ìý

$

137,244

Ìý

Plus:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Consumer Incentives

Ìý

40,799

Ìý

Ìý

Ìý

40,753

Ìý

Ìý

Ìý

76,480

Ìý

Ìý

Ìý

78,362

Ìý

Billings

$

104,048

Ìý

Ìý

$

110,389

Ìý

Ìý

$

201,627

Ìý

Ìý

$

215,606

Ìý

Cardlytics platform

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Revenue

$

58,041

Ìý

Ìý

$

64,002

Ìý

Ìý

$

114,476

Ìý

Ìý

$

126,235

Ìý

Plus:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Consumer Incentives

Ìý

40,799

Ìý

Ìý

Ìý

40,753

Ìý

Ìý

Ìý

76,480

Ìý

Ìý

Ìý

78,362

Ìý

Billings

$

98,840

Ìý

Ìý

$

104,755

Ìý

Ìý

$

190,956

Ìý

Ìý

$

204,597

Ìý

Bridg platform

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Revenue

$

5,208

Ìý

Ìý

$

5,634

Ìý

Ìý

$

10,671

Ìý

Ìý

$

11,009

Ìý

Plus:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Consumer Incentives

Ìý

�

Ìý

Ìý

Ìý

�

Ìý

Ìý

Ìý

�

Ìý

Ìý

Ìý

�

Ìý

Billings

$

5,208

Ìý

$

5,634

Ìý

$

10,671

Ìý

$

11,009

CARDLYTICS, INC.

RECONCILIATION OF GAAP GROSS PROFIT TO ADJUSTED CONTRIBUTION (UNAUDITED)

(Amounts in thousands)

Ìý Ìý

Ìý

Three Months Ended

June 30,

Ìý

Six Months Ended

June 30,

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Revenue

$

63,249

Ìý

Ìý

$

69,636

Ìý

Ìý

$

125,147

Ìý

Ìý

$

137,244

Ìý

Minus:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Partner Share and other third-party costs

Ìý

27,103

Ìý

Ìý

Ìý

33,258

Ìý

Ìý

Ìý

56,553

Ìý

Ìý

Ìý

63,801

Ìý

Delivery costs(1)

Ìý

6,883

Ìý

Ìý

Ìý

7,661

Ìý

Ìý

Ìý

14,171

Ìý

Ìý

Ìý

13,834

Ìý

Gross Profit

Ìý

29,263

Ìý

Ìý

Ìý

28,717

Ìý

Ìý

Ìý

54,423

Ìý

Ìý

Ìý

59,609

Ìý

Plus:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Delivery costs(1)

Ìý

6,883

Ìý

Ìý

Ìý

7,661

Ìý

Ìý

Ìý

14,171

Ìý

Ìý

Ìý

13,834

Ìý

Adjusted Contribution

$

36,146

Ìý

$

36,378

Ìý

$

68,594

Ìý

$

73,443

(1)

Stock-based compensation expense recognized in consolidated delivery costs totaled $0.5 million and $0.7 million during the three months ended June 30, 2025 and 2024, respectively. Stock-based compensation expense recognized in consolidated delivery costs totaled $1.0 million and $1.4 million during the six months ended June 30, 2025 and 2024, respectively.

CARDLYTICS, INC.

RECONCILIATION OF GAAP NET LOSS TO ADJUSTED EBITDA (UNAUDITED)

(Amounts in thousands)

Ìý Ìý

Ìý

Three Months Ended

June 30,

Ìý

Six Months Ended

June 30,

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Net Loss

$

(9,283

)

Ìý

$

(4,257

)

Ìý

$

(22,565

)

Ìý

$

(28,532

)

Plus:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Interest expense, net

Ìý

1,943

Ìý

Ìý

Ìý

1,561

Ìý

Ìý

Ìý

3,773

Ìý

Ìý

Ìý

2,380

Ìý

Depreciation and amortization

Ìý

6,275

Ìý

Ìý

Ìý

6,529

Ìý

Ìý

Ìý

12,566

Ìý

Ìý

Ìý

12,779

Ìý

Stock-based compensation expense

Ìý

7,501

Ìý

Ìý

Ìý

12,644

Ìý

Ìý

Ìý

16,195

Ìý

Ìý

Ìý

23,629

Ìý

Foreign currency (gain) loss

Ìý

(5,449

)

Ìý

Ìý

(99

)

Ìý

Ìý

(8,076

)

Ìý

Ìý

531

Ìý

Gain on debt extinguishment

Ìý

�

Ìý

Ìý

Ìý

(13,017

)

Ìý

Ìý

�

Ìý

Ìý

Ìý

(13,017

)

Acquisition, integration and divestiture costs

Ìý

�

Ìý

Ìý

Ìý

162

Ìý

Ìý

Ìý

�

Ìý

Ìý

Ìý

162

Ìý

Loss (gain) on disposal or divestiture

Ìý

200

Ìý

Ìý

Ìý

�

Ìý

Ìý

Ìý

(5,150

)

Ìý

Ìý

�

Ìý

Change in contingent consideration

Ìý

42

Ìý

Ìý

Ìý

(5,808

)

Ìý

Ìý

102

Ìý

Ìý

Ìý

9

Ìý

Reduction in force

Ìý

1,474

Ìý

Ìý

Ìý

�

Ìý

Ìý

Ìý

1,474

Ìý

Ìý

Ìý

�

Ìý

Adjusted EBITDA

$

2,703

Ìý

Ìý

$

(2,285

)

Ìý

$

(1,681

)

Ìý

$

(2,059

)

CARDLYTICS, INC.

RECONCILIATION OF GAAP NET LOSS TO ADJUSTED NET LOSS

AND ADJUSTED NET LOSS PER SHARE (UNAUDITED)

(Amounts in thousands, except per share amounts)

Ìý Ìý

Ìý

Three Months Ended

June 30,

Ìý

Six Months Ended

June 30,

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Net Loss

$

(9,283

)

Ìý

$

(4,257

)

Ìý

$

(22,565

)

Ìý

$

(28,532

)

Plus:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Stock-based compensation expense

Ìý

7,501

Ìý

Ìý

Ìý

12,644

Ìý

Ìý

Ìý

16,195

Ìý

Ìý

Ìý

23,629

Ìý

Foreign currency (gain) loss

Ìý

(5,449

)

Ìý

Ìý

(99

)

Ìý

Ìý

(8,076

)

Ìý

Ìý

531

Ìý

Gain on debt extinguishment

Ìý

�

Ìý

Ìý

Ìý

(13,017

)

Ìý

Ìý

�

Ìý

Ìý

Ìý

(13,017

)

Acquisition, integration and divestiture costs

Ìý

�

Ìý

Ìý

Ìý

162

Ìý

Ìý

Ìý

�

Ìý

Ìý

Ìý

162

Ìý

Amortization of acquired intangibles

Ìý

1,455

Ìý

Ìý

Ìý

2,785

Ìý

Ìý

Ìý

2,909

Ìý

Ìý

Ìý

5,574

Ìý

Loss (gain) on disposal or divestiture

Ìý

200

Ìý

Ìý

Ìý

�

Ìý

Ìý

Ìý

(5,150

)

Ìý

Ìý

�

Ìý

Change in contingent consideration

Ìý

42

Ìý

Ìý

Ìý

(5,808

)

Ìý

Ìý

102

Ìý

Ìý

Ìý

9

Ìý

Reduction in force

$

(1,474

)

Ìý

$

�

Ìý

Ìý

$

(1,474

)

Ìý

$

�

Ìý

Adjusted Net Loss

$

(7,008

)

Ìý

$

(7,590

)

Ìý

$

(18,059

)

Ìý

$

(11,644

)

Weighted-average number of shares of common stock used in computing Adjusted Net Loss per share:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Weighted-average common shares outstanding, diluted

Ìý

52,750

Ìý

Ìý

Ìý

49,056

Ìý

Ìý

Ìý

52,309

Ìý

Ìý

Ìý

46,168

Ìý

Adjusted Net Loss per share, diluted

$

(0.13

)

Ìý

$

(0.15

)

Ìý

$

(0.35

)

Ìý

$

(0.25

)

CARDLYTICS, INC.

RECONCILIATION OF NET CASH USED IN OPERATING ACTIVITIES TO FREE CASH FLOW (UNAUDITED)

(Amounts in thousands)

Ìý Ìý

Ìý

Three Months Ended

June 30,

Ìý

Six Months Ended

June 30,

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Net cash used in operating activities

$

1,227

Ìý

Ìý

$

4,430

Ìý

Ìý

$

(5,481

)

Ìý

$

(13,188

)

Plus:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Acquisition of property and equipment

Ìý

(322

)

Ìý

Ìý

(281

)

Ìý

Ìý

(441

)

Ìý

Ìý

(932

)

Capitalized software development costs

Ìý

(4,336

)

Ìý

Ìý

(4,577

)

Ìý

Ìý

(8,320

)

Ìý

Ìý

(8,673

)

Free Cash Flow

$

(3,431

)

Ìý

$

(428

)

Ìý

$

(14,242

)

Ìý

$

(22,793

)

CARDLYTICS, INC.

RECONCILIATION OF FORECASTED GAAP REVENUE TO BILLINGS (UNAUDITED)

(Amounts in thousands)

Ìý Ìý

Ìý

Q3 2025

Revenue

$52.2 - $58.2

Plus:

Ìý

Consumer Incentives

$28.8 - $42.8

Billings

$87.0 - $95.0

Ìý

Public Relations:

[email protected]

Investor Relations:

[email protected]

Source: Cardlytics, Inc.

Cardlytics

NASDAQ:CDLX

CDLX Rankings

CDLX Latest News

CDLX Latest SEC Filings

CDLX Stock Data

96.60M
51.06M
2.74%
55.22%
12.22%
Advertising Agencies
Services-computer Programming, Data Processing, Etc.
United States
ATLANTA